Randox at Medica TradeFair 2018 - Stand No. 3A08

Location : Düsseldorf
  Date : 12th - 15th November 2018

Cardiac Risk


Randox are at the forefront of developing high quality diagnostic solutions for the cardiology field. We are revolutionising the early detection of cardiovascular disease through our innovations that make a real difference to both the clinician and the patient.



HDL2/3-C is a subfraction of the HDL particle. Elevated levels of HDL2/3-C reflect increased triglyceride content of the HDL particle. Randox are proud to present a new automated biochemistry assay for the measurement of HDL2/3-C.
Key Features of Randox HDL2/3-C:

  • Liquid ready-to-use
  • Available on most automated biochemistry analysers
  • A 2 step procedure based on patented technology from Denka Seiken
  • Open vial stability of 28 days at +2 to +8°C
  • Dedicated calibrator available
  • Measuring range of 4 – 60mg/dl
  • Demonstrates a strong correlation with the conventional Ultracentrifugation method
  • Allows for quantification of HDL2-C by the subtraction of HDL3-C from total HDL-C
  • Measures total HDL2/3-C.



Apolipoprotein B

Apolipoprotein B is often tested alongside Apolipoprotein A-I to determine the Apolipoprotein B/Apolipoprotein A-I ratio which can be used as an alternative to the Total Cholesterol /HDL Cholesterol ratio when determining cardiovascular risk.
Key features:

  • Liquid ready-to-use reagents – for convenience and ease-of-use
  • Extensive measuring range – of 11.2-184mg/dl for measurement of clinically important results
  • Limited interference – from Bilirubin, Haemoglobin, Intralipid® and Triglycerides, producing more accurate results
  • Applications available for an extensive range of biochemistry analysers– which detail instrument-specific settings for the convenient use of Randox Apolipoprotein B assays on a variety




Raised levels of homocysteine can be associated with various disease states including cardiovascular disease, diabetes, dementia, osteoporosis and complications during pregnancy, making homocysteine an essential addition to a laboratory’s testing panel.

  • 2-part liquid ready-to-use kit with calibrators included
  • Minimal interference – ensuring accurate and precise results are produced every time
  • Excellent measuring range – 1.74-47.9µmol/l, enabling the Randox assay to detect abnormal levels related to all homocysteine associated disease states




Elevated levels of Lipoprotein(a) (Lp(a)) are considered to be both a causal risk factor and independent genetic marker of atherosclerotic disorders. The major challenge with this test is the size variation of apo(a) within Lp(a). Dependent upon the size of apo(a) in the assay calibrator, many assays under or overestimate apo(a) size in the patient sample. The antibody used in the Randox method detects the complete Lp(a) molecule providing the most accurate and consistent results.

  • Liquid ready-to-use reagents
  • Superior methodology – displaying minimal Apo(a) size related bias
  • Five point calibrator available – giving a true reflection of the isoforms present in the population